Featured Research

from universities, journals, and other organizations

Health Risks, Economic Burden Of Migraine Reviewed

Date:
February 11, 2009
Source:
Wiley-Blackwell
Summary:
A new study published in Value in Health reviews the economic burden of migraine in the US and recent clinical findings of the health risks of this neurological condition.

A new study published in Value in Health reviews the economic burden of migraine in the U.S. and recent clinical findings of the health risks of this neurological condition. This study traces the history of economic articles published on migraine using the PubMed Medline database and archival searches of relevant articles to identify possible health risks associated with migraines that warrant further study.

Migraine affects millions of individuals worldwide. Sufferers experience substantial decreases in functioning and productivity, results which in turn translate into diminished quality of life for individuals, financial burdens for health care systems and substantial lost work time that impacts individuals, employers, and societies alike. Migraine is a condition most prevalent in individuals between the ages of 25 and 55, generally the most productive years of a person’s life.

Migraine is often perceived as a condition that imposes a minimal burden on society and the health care system. This misperception persists in part because the disorder is episodic and rarely causes long-term physical disability. Because it is under-diagnosed and under-treated, analyses of claims data underestimate the condition’s prevalence and economic impact.

Recent clinical studies suggest that migraine may be a progressive disease with cardiovascular, cerebrovascular and long-term neurologic effects. Suffering from migraines may also be a risk factor for brain lesions. Additionally, studies following those who suffer from migraine with aura (sensory, motor or visual disturbances that can precede or accompany the headache) have shown these individuals to be twice as likely as the general population to develop major cardiovascular disease and suffer stroke. If such findings are confirmed, treatments, approaches and economic evaluations of migraine treatment may require major reconsideration.

Epidemiologic studies have recently indicated that 4 percent to 5 percent of the general population suffers from chronic daily migraine headache, a condition characterized by 15 or more headache days per month, and that transformed migraine—the transformation of episodic migraine to the chronic form of the disorder—accounts for approximately half of these patients.

Currently, most physicians do not think of migraine as they do illnesses such as diabetes, hypertension, asthma or rheumatoid arthritis. Nevertheless, migraine may need to be reexamined from a similar perspective as a chronic illness for which preventive therapy is important to delay or reduce more serious forms or complications.


Story Source:

The above story is based on materials provided by Wiley-Blackwell. Note: Materials may be edited for content and length.


Journal Reference:

  1. Hazard et al. The Burden of Migraine in the United States: Current and Emerging Perspectives on Disease Management and Economic Analysis. Value in Health, 2009; 12 (1): 55 DOI: 10.1111/j.1524-4733.2008.00404.x

Cite This Page:

Wiley-Blackwell. "Health Risks, Economic Burden Of Migraine Reviewed." ScienceDaily. ScienceDaily, 11 February 2009. <www.sciencedaily.com/releases/2009/02/090202175153.htm>.
Wiley-Blackwell. (2009, February 11). Health Risks, Economic Burden Of Migraine Reviewed. ScienceDaily. Retrieved April 23, 2014 from www.sciencedaily.com/releases/2009/02/090202175153.htm
Wiley-Blackwell. "Health Risks, Economic Burden Of Migraine Reviewed." ScienceDaily. www.sciencedaily.com/releases/2009/02/090202175153.htm (accessed April 23, 2014).

Share This



More Health & Medicine News

Wednesday, April 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Big Pharma Braces for M&A Wave

Big Pharma Braces for M&A Wave

Reuters - Business Video Online (Apr. 22, 2014) Big pharma on the move as Novartis boss, Joe Jimenez, tells Reuters about plans to transform his company via an asset exchange with GSK, and Astra Zeneca shares surge on speculation that Pfizer is looking for a takeover. Joanna Partridge reports. Video provided by Reuters
Powered by NewsLook.com
Study Says Most Crime Not Linked To Mental Illness

Study Says Most Crime Not Linked To Mental Illness

Newsy (Apr. 22, 2014) A new study finds most crimes committed by people with mental illness are not caused by symptoms of their illness or disorder. Video provided by Newsy
Powered by NewsLook.com
Hagel Gets Preview of New High-Tech Projects

Hagel Gets Preview of New High-Tech Projects

AP (Apr. 22, 2014) Defense Secretary Chuck Hagel is given hands-on demonstrations Tuesday of some of the newest research from DARPA _ the military's Defense Advanced Research Projects Agency program. (April 22) Video provided by AP
Powered by NewsLook.com
How Smaller Plates And Cutlery Could Make You Feel Fuller

How Smaller Plates And Cutlery Could Make You Feel Fuller

Newsy (Apr. 22, 2014) NBC's "Today" conducted an experiment to see if changing the size of plates and utensils affects the amount individuals eat. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins